ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive: The resultant chimeric gene—bcr‐abl oncogene encodes for a constitutively active tyrosine kinase protein that is central to the pathogenesis of CML, since it alters proliferation, cell death, and adherence/migration of the neoplastic cells 4.